نتایج جستجو برای: expanded disability status scale edss

تعداد نتایج: 1070294  

2011
M. J. Eikelenboom B. M. J. Uitdehaag A. Petzold

Background. Disability in multiple sclerosis (MS) is related to neuroaxonal degeneration. A reliable blood biomarker for neuroaxonal degeneration is needed. Objectives. To explore the relationship between cerebrospinal fluid (CSF) and serum concentrations of a protein biomarker for neuroaxonal degeneration, the neurofilaments heavy chain (NfH). Methods. An exploratory cross-sectional (n = 51) a...

Journal: :International Journal of Rehabilitation Research 2021

Fatigue and walking difficulties are common impairments activity limitations in persons with multiple sclerosis (PwMS). Walking fatigability (WF) can be measured by a Distance Walked Index is defined as decline distance of 10% or more during the six-minute test (6MWT). However, clinical manifestation perceived symptoms related to still not well documented. Forty-nine PwMS [Expanded Disability S...

Journal: :European journal of neurology 2012
M B D'hooghe P Haentjens G Nagels J De Keyser

BACKGROUND Certain lifestyle factors might influence disease activity in multiple sclerosis (MS). OBJECTIVES To investigate the consumption of alcoholic beverages, caffeinated drinks, fish and cigarette smoking in relation to disability progression in relapsing onset and progressive onset MS. METHODS We conducted a cross-sectional survey amongst individuals with MS, registered by the Flemis...

2013
Jop Mostert Thea Heersema Manju Mahajan Jeroen Van Der Grond Mark A. Van Buchem Jacques De Keyser

Preclinical studies suggest that fluoxetine may have neuroprotective properties. In this pilot study forty-two patients with secondary or primary progressive MS were randomized to receive fluoxetine 20 mg twice daily or placebo for 2 years. Every 3 months the Expanded Disability Status Scale (EDSS), 9-hole peg test (9-HPT) and ambulation index (AI) were assessed. Brain MRI scans, Multiple Scler...

2017
Pablo Villoslada Cristina Alonso Ion Agirrezabal Ekaterina Kotelnikova Irati Zubizarreta Irene Pulido-Valdeolivas Albert Saiz Manuel Comabella Xavier Montalban Luisa Villar Jose Carlos Alvarez-Cermeño Oscar Fernández Roberto Alvarez-Lafuente Rafael Arroyo Azucena Castro

OBJECTIVE To identify differences in the metabolomic profile in the serum of patients with multiple sclerosis (MS) compared to controls and to identify biomarkers of disease severity. METHODS We studied 2 cohorts of patients with MS: a retrospective longitudinal cohort of 238 patients and 74 controls and a prospective cohort of 61 patients and 41 controls with serial serum samples. Patients w...

Journal: :Multiple sclerosis and related disorders 2021

BackgroundAnti-CD20 antibody therapy may be associated with an increased risk of infections. We therefore investigated factors for infection in patients demyelinating diseases treated anti-CD20 therapy.MethodsIn this retrospective uncontrolled study, ever antibodies at academic clinic were identified through the Danish Multiple Sclerosis Registry (DMSR). Data collected from medical charts and D...

Journal: :Multiple sclerosis 2016
J Kuhle M Hardmeier G Disanto K Gugleta M Ecsedi C Lienert M P Amato K Baum M Buttmann A Bayas D Brassat B Brochet C Confavreux G Edan M Färkkilä S Fredrikson M Frontoni M D'Hooghe M Hutchinson J De Keyser B C Kieseier T Kümpfel J Rio C Polman E Roullet C Stolz K Vass K P Wandinger L Kappos

OBJECTIVES To explore long-term effects of treatment and prognostic relevance of variables assessed at baseline and during the European secondary progressive multiple sclerosis (SPMS) trial of interferon beta 1b (IFNB-1b). METHODS We assessed 362 patients (60% female; median age 41 years; Expanded Disability Status Scale (EDSS): 5.5; 51% randomized to IFNB-1b) for their EDSS and treatment his...

Journal: :Journal of neurology, neurosurgery, and psychiatry 1995
M Trojano C Avolio C Manzari A Calò F De Robertis G Serio P Livrea

The clinical data of 309 patients with definite multiple sclerosis were recorded in the European data base for multiple sclerosis (EDMUS) to determine the prognostic significance of several demographic and clinical variables. An interview with closed questions structured according to standardised criteria of disease phases and courses was used to assess the clinical course. The reliability was ...

2013
Simone Kern Ivonne Krause Antje Horntrich Katja Thomas Julia Aderhold Tjalf Ziemssen

OBJECTIVES Dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis has frequently been reported in multiple sclerosis (MS). So far, HPA axis function in MS has predominantly been studied under pharmacological stimulation which is associated with a series of methodological caveats. Knowledge of circadian cortisol patterns and cortisol awakening response (CAR) is still limited. METHODS A...

2015
Christian Veauthier Gunnar Gaede Helena Radbruch Joern-Peter Sieb Klaus-Dieter Wernecke Friedemann Paul

BACKGROUND There are few studies describing periodic limb movement syndrome (PLMS) in rapid eye movement (REM) sleep in patients with narcolepsy, restless legs syndrome, REM sleep behavior disorder, and spinal cord injury, and to a lesser extent, in insomnia patients and healthy controls, but no published cases in multiple sclerosis (MS). The aim of this study was to investigate PLMS in REM sle...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید